Search

everythinglearnresearchcommunity

for

Search:↓

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

More precise, personalized therapies are needed for autoimmune diseases.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Higher CRHR1 levels in AA patients lead to increased inflammation.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

SPT6 prevents excessive skin inflammation by blocking a feedback loop.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Certain substances can help skin cells become anti-inflammatory, aiding in tissue repair.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Ustekinumab helped three kids with alopecia areata regrow hair.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

JAK inhibitors show promise for treating skin diseases effectively and safely.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Probiotics significantly reduce the severity of atopic dermatitis.

Mouse hair cells respond to male hormones by growing less, and this can be stopped by certain blockers.